Wow. Someone actually didn't like what I had to say. Tried to warn you.
Chesapeake Energy (CHK), a Williams Cos. customer, has reportedly hired lawyers to help restructure a $9.8 billion debt load.
I agree. Was listening to recent weekly Podcast, 2-1-16, by Tortoise Capital Advisors, which is a leading player in energy investing. Basically stated that Mr. Market is rewarding discipline in cutting spending even if net results in lower future growth. I personally wouldn't mind a 50% divy cut and 10-20% Capex cut (just suspending projects until better environment).
They need to do something quickly or this deal won't happen anyway if this stock is like at 3-4 dollars. Can't see WMB voting on a merger with ETE at 3-4, unless Management wants WMB to back out without losing the upfront money. Probably could get a better deal by waiting a little longer. GLTA
It is all about uncertainty. Mr. Market is punishing ETE about that. KMI has had it earnings and provided guidance and plans on what is being done to cope with low oil. ETE has not. Plus, alot of uncertainty about the merger. Typical Wall Street movie. Spread fear while shorting and covering at much lower prices.
R U aware that as of last earnings, only 18% of roughly 10.6 billion in revenue came from crude sales. The other % came from NG/LNG sales, refined products, etc. They have a downstream network of refined products pipelines and retail gasoline stations that offer a counter-cyclical offset by benefiting from lower oil and gas prices. Like XOM and Chevron do.
There is roughly about a 2 million barrels a day oversupply problem. US alone produces about 9 million barrels a day. I doubt the US will be the only country cutting and that all the oil being cut is flowing through ETEs pipelines. ETE can easily have capex cut or sell nonproducing assets if needed.
Avoid those MLPs which pay IDRs (Incentive Distribution Payments) to their general partner. This diabolical invention allows the general partner to skim off as much as 50% of the partnership's cash flow. Follow the insiders
Says who? The share price is what Mr. Market thinks of their current value and that is all that matters.
Your math is flawed.Total Debt (mrq): 2.65B. Plus, they will be lucky to sell their assets for pennies on the dollar since so many are sitting idle in this environment.
Hey, good to see you are still around. Going to start buying for a swing. Going to follow three day rule. Seems like a lot of the old gang is gone.
Be careful with COP. Earnings estimate for 2015 is only .84 but annual dividend is $2.92. I like RDS-A better. No position yet. But making a shopping list.
Total shareholders' equity 505,456 from last earnings. What am I missing? I am getting 1.64 a share based on 307.8m shares outstanding.
This is from my Blue Cross and Blue Shield policy.
"Galectin-3 testing is considered experimental, investigational and unproven for all indications including but not limited to, selection of individuals for biventricular testing and to determine prognosis of heart failure."
Remember, they already have a partnership. Probably 50/50. BGMD spent money on the scientific studies and literature validating the need for the test and Abbott spent money on automating the test and paying for the 510(K) filings. BGMD needed Abbott for survival as they were losing sales to competitors on the manual version.
So for starters they would be buying out their partners half.
I agree. The test is FDA approved to use in an effort to keep people from coming back for heart failure (readmisson purposes). Not diagnosis purposes. Like a routine blood pressure test. Don't forget about pressure from Insurance companies.
Fom what I gather is no. Just re-admission at this time. But I believe the thinking is that over time the use for the test will expand, to include for other conditions.
It is already on the Architect. They are already partners with BGMD. Abbott has been working with BGMD for over 5 years on the automated version for US and paid for the 510(k). They wouldn't be wasting their time and money if they didn't see value. Abbott is calling the shots on this and not BGMD. Market is waiting on Abbott.